Literature DB >> 7440107

Degranulation of ocular mast cells in rats undergoing systemic anaphylaxis.

M R Allansmith, R S Baird, K J Bloch.   

Abstract

The percentage of degranulated ocular mast cells in five egg albumin--immunized, systemically challenged rats was compared with that in five egg albumin--immunized, saline-challenged controls. For the lid and orbit, at least 100 mast cells per rat were evaluated. For the conjunctiva, tarsus, limbus, and episclera-sclera, at least 20 were evaluated. For the ciliary body and choroid, all mast cells in 15 sections separated by at least 15 micrometer were examined. The morphology of degranulated and intact mast cells was the same in the experimental and control animals, except for the change in granules. There were significantly more degranulated mast cells in most of the ocular tissues of rats undergoing systemic anaphylaxis than in tissues of controls rats; the increase in degranulated cells was especially striking in the choroid. We concluded that degranulation of mast cells is a measure of anaphylaxis, provided that the number of degranulated mast cells, and not simply the presence of such cells, is considered and compared with appropriate controls.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440107

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

Review 1.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 2.  Characterization of the choroidal mast cell.

Authors:  W A Godfrey
Journal:  Trans Am Ophthalmol Soc       Date:  1987

3.  Sequence of mast-cell changes in ocular anaphylaxis.

Authors:  M R Allansmith; R S Baird; A S Henriquez; K J Bloch
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

Review 4.  Animal models of ocular allergy and their clinical correlations.

Authors:  Margarita Calonge; Karyn F Siemasko; Michael E Stern
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.